These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34229091)

  • 21. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.
    Forbes G; Loudon K; Treweek S; Taylor SJC; Eldridge S
    J Clin Epidemiol; 2017 Oct; 90():119-126. PubMed ID: 28629699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The PRECIS-2 tool: designing trials that are fit for purpose].
    Hu GP; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements.
    Nieuwenhuis JB; Irving E; Oude Rengerink K; Lloyd E; Goetz I; Grobbee DE; Stolk P; Groenwold RH; Zuidgeest MG;
    J Clin Epidemiol; 2016 Sep; 77():95-100. PubMed ID: 27164273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designing a valid randomized pragmatic primary care implementation trial: the my own health report (MOHR) project.
    Krist AH; Glenn BA; Glasgow RE; Balasubramanian BA; Chambers DA; Fernandez ME; Heurtin-Roberts S; Kessler R; Ory MG; Phillips SM; Ritzwoller DP; Roby DH; Rodriguez HP; Sabo RT; Sheinfeld Gorin SN; Stange KC;
    Implement Sci; 2013 Jun; 8():73. PubMed ID: 23799943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pragmatic trials and implementation science: grounds for divorce?
    Pawson R
    BMC Med Res Methodol; 2019 Aug; 19(1):176. PubMed ID: 31420024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence.
    Margolis KL; Crain AL; Green BB; O'Connor PJ; Solberg LI; Beran M; Bergdall AR; Pawloski PA; Ziegenfuss JY; JaKa MM; Appana D; Sharma R; Kodet AJ; Trower NK; Rehrauer DJ; McKinney Z; Norton CK; Haugen P; Anderson JP; Crabtree BF; Norman SK; Sperl-Hillen JM
    Trials; 2022 Aug; 23(1):673. PubMed ID: 35978336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
    Norton WE; Loudon K; Chambers DA; Zwarenstein M
    Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.
    Ettori-Ajasse I; Tatin E; Forbes G; Eldridge S; Dibao-Dina C
    Trials; 2020 Mar; 21(1):281. PubMed ID: 32188470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges of a community based pragmatic, randomised controlled trial of weight loss maintenance.
    Randell E; McNamara R; Shaw C; Espinasse A; Simpson SA
    BMC Res Notes; 2015 Dec; 8():802. PubMed ID: 26683473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
    Thorpe KE; Zwarenstein M; Oxman AD; Treweek S; Furberg CD; Altman DG; Tunis S; Bergel E; Harvey I; Magid DJ; Chalkidou K
    J Clin Epidemiol; 2009 May; 62(5):464-75. PubMed ID: 19348971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice.
    Koppenaal T; Linmans J; Knottnerus JA; Spigt M
    J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.
    Weinfurt KP; Hernandez AF; Coronado GD; DeBar LL; Dember LM; Green BB; Heagerty PJ; Huang SS; James KT; Jarvik JG; Larson EB; Mor V; Platt R; Rosenthal GE; Septimus EJ; Simon GE; Staman KL; Sugarman J; Vazquez M; Zatzick D; Curtis LH
    BMC Med Res Methodol; 2017 Sep; 17(1):144. PubMed ID: 28923013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease.
    Nguyen HQ; Moy ML; Fan VS; Gould MK; Xiang A; Bailey A; Desai S; Coleman KJ
    Nurs Outlook; 2018 Sep; 66(5):455-463. PubMed ID: 30144938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Oncology Trials in the Real World: Assessing the Pragmatism of an Ongoing Integrative Oncology Trial of Mindfulness and T'ai Chi/Qigong.
    Carlson LE; Oberoi DV; Qureshi M; Subnis U
    J Altern Complement Med; 2018; 24(9-10):926-932. PubMed ID: 30247962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.
    Dal-Ré R
    Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of published trials found that current use of pragmatic trial labels is uninformative.
    Taljaard M; Nicholls SG; Howie AH; Nix HP; Carroll K; Moon PM; Nightingale NM; Giraudeau B; Hey SP; Eldridge SM; Weijer C; Zwarenstein M
    J Clin Epidemiol; 2022 Nov; 151():113-121. PubMed ID: 35987403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of intervention design and delivery in pragmatic and explanatory surgical randomized clinical trials.
    Blencowe NS; Boddy AP; Harris A; Hanna T; Whiting P; Cook JA; Blazeby JM
    Br J Surg; 2015 Aug; 102(9):1037-47. PubMed ID: 26041565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Ré R; Janiaud P; Ioannidis JPA
    BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.
    Nicholls SG; Carroll K; Hey SP; Zwarenstein M; Zhang JZ; Nix HP; Brehaut JC; McKenzie JE; McDonald S; Weijer C; Fergusson DA; Taljaard M
    J Clin Epidemiol; 2021 Sep; 137():45-57. PubMed ID: 33789151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials.
    Bratton DJ; Nunn AJ
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):440-6. PubMed ID: 21396200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.